An interventional study of Ultrasound beams Philips HD11 XE® in Myocardial Infarction and ST Elevation Myocardial Infarction, sponsored by Sakarya University. Status unknown at 1 site in Turkey. Open to participants aged 18 Years to 80 Years. Per ClinicalTrials.gov, last updated 2014-11-24.
Sponsored by Sakarya University · Not applicable, Interventional, and Supportive care
Successfully perfused STEMI patients will receive routine transthoracic echocardiography qid for 4 days or placebo. Myocardial function and infarct size will be evaluated at 3 and 6 months.
Patients who had acute STEMI and successfully reperfused by either thrombolytic therapy or primary angioplasty and stenting will be included this study.
A basal routine echocardiography will be obtained in all patients after reperfusion therapy. Thereafter, patients will be divided into two groups: 1.Treatment group will receive transthoracic echocardiography using Philips HD11 XE ® for 30 minutes qid for 4 days. 2. Placebo group will have the same Philips HD11 XE ® echo transducer applied for the same time and duration on their chest but with the ultrasound turned-off. Detailed left and right ventricle function as well as performance index and stress-strain imaging will be obtained and analyzed at 3 and 6 months.
2,744 studies on the registry are indexed under Myocardial Infarction; 418 are open to participants now.
This study's planned enrollment of 100 is below the median of 148 across 1,595 interventional studies indexed under Myocardial Infarction.
Browse Myocardial Infarction studies →Sakarya University is the lead sponsor of 178 studies on the registry; 48 are open to participants now.
Counted across the registry records on this site, refreshed daily.
-Patients presenting within 12 hours of their first ST- elevation myocardial infarction that is successfully reperfused; and completed baseline echocardiographic evaluation and accepted participation in the study
Exclusion criteria:
Patients:
Philips HD11 XE® 30 min qid x 4 days
Other: Ultrasound beams Philips HD11 XE®
Philips HD11 XE® (ultrasound turned-off) 30 min qid x 4 days
Other: Ultrasound beams Philips HD11 XE®
Ultrasound beams used during standard echocardiography
Increase in left ventricular function
Ultrasound beams during echocardiography application expected to ameliorate the left ventricle function
Time frame: At 3 and 6 months
Decrease in infarct size
Ultrasound beams during echocardiography application expected to decrease infarct size
Time frame: At 3 and 6 months
This study is status unknown, as verified in Nov 2014. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Sakarya University